ITI is a program of The Task Force for Global Health.
Eritrea started mapping for trachoma in 2006 with 17 districts showing an active trachoma prevalence over the 5% TF threshold.
The national trachoma program started implementation in 2011 with seven districts receiving Zithromax®.
Eritrea’s trachoma program has made extraordinary progress and is ahead of its neighbors Ethiopia and Sudan in reaching the 2020 elimination goal, despite a lack of resources, including consistent electricity, Internet, phone service, and access to reliable transportation.
In 2017, Eritrea’s national trachoma program will have conducted MDAs in 14 districts using Pfizer’s donation of Zithromax® and funding from the Fred Hollows Foundation and The End Fund.
In April 2016, ITI funded a TAP workshop and the resulting TAP document has helped foster the writing efforts of the five-year National Blindness Prevention Plan.
Zithromax® Shipments by Year